Key Highlights
- Aehr Test Systems (NASDAQ:AEHR) shares slid 15.98% to USD 40.28 on November 20, 2026.
- Fiscal first quarter Revenue was a record USD 33.0 million.
- Full-year revenue guidance was raised to USD 150 million.
- The semiconductor index slid roughly 6% to 7% intraday.
A Semiconductor Rout Hits a High-Beta Name
Aehr Test Systems (NASDAQ:AEHR), a maker of test and burn-in equipment for semiconductors, slid 15.98% to USD 40.28 on November 20, 2026, on trading Volume of 2.33 million shares. There was no company-specific news on the day. The drop came as the semiconductor index slid roughly 6% to 7% intraday, with Micron, AMD and Onto Innovation sharply lower, as rate-hike fears and valuation worries added to pressure after the AI trade failed to revive. The shares have a Beta near 3.4, which means they tend to move much more than the market, and extended a slide from a 50-day average near USD 75. Over 52 weeks the shares have traded from USD 18.70 to USD 147.40. Burn-in testing stresses chips under heat and voltage to find early failures, and Demand has grown as AI processors and power chips need higher reliability. Aehr's systems can test many chips at once, which is why the equipment suits high-volume chip production. The company's customers include makers of silicon carbide and AI processors, and orders can arrive in uneven batches.
Strong Fundamentals Versus a Weak Tape
Fiscal first quarter revenue of USD 33.0 million was a record, triple the figure from a year earlier and above estimates, and full-year revenue guidance was raised to USD 150 million. The stock carries a market Capitalization of about USD 1.33 billion, trailing diluted EPS is USD 0.03 and the forward price to Earnings ratio is 39.14. Trimmed targets from Jefferies and Lake Street reflect lower sector multiples, not weaker fundamentals, and the bullish view is that the pullback is a buying opportunity. The trailing multiple of more than 800 shows how small current profit is against the share price. The company's trailing profit is close to zero, so the share price depends on expected growth. When sector multiples fall, a stock priced for growth can lose value fast even if the Business is on track, which is the pattern seen on November 20.
Risks: Valuation, Insider Sales and Concentration
Skeptics argue that valuation remains demanding against sales, and that insider selling of about USD 62.5 million and weak momentum signals add pressure. The premium leaves little room for disappointment. Customer concentration is a risk, since a few large buyers drive orders, and converting AI demand and Backlog into revenue and profit takes time. Profitability is thin, so earnings are sensitive to margins. A stock with a beta near 3.4 can swing sharply in both directions, so the quoted move can deepen or reverse quickly. Insider sales are not unusual after a large run-up, but investors often watch them for signs of caution. The 52-week high of USD 147.40 sits far above the current price, so many buyers at higher levels may choose to sell into rallies. Analysts' lower targets also hint that earnings estimates may drift lower if orders slip.
Where Things Stand
Aehr Test Systems (NASDAQ:AEHR) slid because a broad semiconductor sell-off hit a high-beta name, despite record fiscal first quarter revenue and raised full-year guidance of USD 150 million. Trimmed targets reflect lower sector multiples. On the flip side, valuation is demanding, insiders have sold about USD 62.5 million and customers are concentrated. The next Quarterly Report will test whether orders turn into revenue. Traders should treat the quoted move as volatile, not final. The stock is US-listed, so this reflects Friday's US session.






Please wait processing your request...